AVR.AX

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Devices

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$10M	+288.7%	$-1.71	$-3.29–$-0.08	—	2
2027	$14M	+39.1%	$-1.58	$-3.04–$-0.07	—	2
2028	$23M	+64.7%	$-1.16	$-1.35–$-1.02	—	3
2029	$172M	+648.2%	$-0.95	$-1.82–$-0.04	—	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Earnings surprises

Beat consensus in 0 of the last 6 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-08-10	$-0.29	$-0.42	-44.2%
2026-05-12	$-0.38	$-0.39	-2.2%
2025-11-11	$-0.83	$-0.95	-14.0%
2025-05-12	$-0.84	$-0.94	-12.6%
2024-10-31	$-1.50	$-2.75	-83.3%
2024-08-22	$-1.50	$-2.75	-83.3%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
AVR.AXAnteris Technologies Ltd	$12.00	+3.99%	$1.2B	—
AFP.AXAFT Pharmaceuticals Limited	$3.43	+0.15%	$360M	—
ARX.AXAroa Biosurgery Limited	$0.56	+0.90%	$193M	—
AVH.AXAVITA Medical, Inc.	$2.80	+3.70%	$348M	—
BOT.AXBotanix Pharmaceuticals Limited	$0.02

Anteris Technologies Ltd

Anteris Technologies Ltd is a firm specializing in the structural heart domain. It is responsible for the production and distribution of ADAPT, a product based on regenerative tissue technology. The company is also actively involved in advancing DurAVR™, an innovative 3D single-component aortic valve specifically designed for treating aortic stenosis. Additionally, Anteris allocates resources to the research and development of regenerative medicines. Founded in 1999, the enterprise was formerly known as Admedus Limited until it rebranded to Anteris Technologies Ltd in May 2020. Its primary operations are conducted from its base in Toowong, Australia.

www.anteristech.com

Employees: 174
IPO / List date: Mar 22, 2004
HQ: AU

Held by traders on TradeandTell

No one on the platform currently holds AVR.AX.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in AVR.AX as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded AVR.AX yet.